$Longeveron (LGVN.US)$ are trading higher on continued upwar...

$Longeveron (LGVN.US)$ are trading higher on continued upward momentum after the company announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome.
$Harbor Custom Development (HCDI.US)$ Co had good earnings on 15th. CFO and directors purchased shares on friday
$Trio-Tech International (TRT.US)$ unable to hold $10 support. On watch if it makes another attempt.
$BriaCell Therapeutics (BCTX.US)$ going down with the market. If it continues to hold above $10 it can see some more momentum.
$Innoviz Technologies (INVZ.US)$ CO reported earnings recently and got analyst PT of $9. Having a nice trend. Adding if breaks and holds $7.50